Diabetes and Cardiovascular Disease Interventions by Community Pharmacists: A Systematic Review

Abstract

Poor study quality, time-intensive interventions, and unproven clinical significance warrant the need for further high-quality studies of community pharmacist interventions for preventing or managing diabetes or CVD and/or their major risk factors.

Project ImPACT: Hypertension Outcomes of a Pharmacist-Provided Hypertension Service

“…[22][23][24] However, changes in adherence with educational efforts have historically been difficult to demonstrate. 16,25 Limitations A key limitation to this report that deserves discussion is that the duration was 4 visits or 6 months in length. This time frame was potentially inconsistent between patients due to scheduling changes that caused deviations from the 6-week recurring appointment schedule.…”

“…14 Since that time, the impact of pharmacist involvement in the management and outcomes in patients with hypertension has been demonstrated in multiple settings showing improvements in blood pressure control and other cardiovascular risk factors. 15,16 Pharmacists have notably been reported to have significant impact on hypertension control rates when electronically engaged with patients for consultation in combination with web-based education and home blood pressure monitoring. 17 Most recently, home blood pressure telemonitoring along with pharmacistprovided management and dosage adjustments have significantly improved hypertension control in patients.…”

Support for community pharmacy-based alcohol interventions: a Scottish general public survey

“…[18][19][20][21][22][23][24][25] It also builds on existing knowledge of public trust in pharmacists more widely, as evidenced in narrative and systematic reviews of pharmacy based public health activities. [10][11][12][13][14] .…”

Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach

“…12,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] Few studies, however, have been conducted in Hong Kong. 17,29 In view of inadequate available data and potential for expansion of local pharmacy services, more studies are required to investigate the future development of a sustainable diabetes service provided by pharmacists.…”